Qu Biologics Granted Broad Australian Patent for Targeted Treatment of Multiple Cancers
January 22, 2014 10:10 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 22, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to reboot the body's...
Qu Biologics Appoints Rashieda Gluck as Vice President, Clinical Operations
December 11, 2013 11:05 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 11, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to 'reboot' the...
Qu Biologics Granted Broad European Patent for Targeted Treatment of Multiple Cancers
December 06, 2013 05:30 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 6, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to reboot the body's...
Qu Biologics Appoints Dr. David Mullins as Chief Scientific Officer
December 04, 2013 09:45 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to 'reboot' the body's...
Qu Biologics Begins Research with McMaster University to Study New Crohn's Disease Research Model
December 03, 2013 10:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to stimulate the...
Qu Biologics Begins Research With McMaster University to Study Chronic Inflammation Associated With Macrophage Dysfunction
August 15, 2013 12:42 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 15, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
Qu Biologics Introduces Travel Subsidy Program for Crohn's Clinical Trial Participants
July 30, 2013 12:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 30, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
Qu Biologics Initiates Study of Site Specific Immunomodulators at Geisel School of Medicine at Dartmouth
July 03, 2013 12:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Appoints Former Novartis President Mr. Robert Pelzer to its Board of Directors
June 13, 2013 13:41 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 13, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
Qu Biologics Enrolls First Patient in Phase 1/2 Clinical Trial of QBECO SSI for the Treatment of Crohn's Disease
June 11, 2013 16:22 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 11, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...